Endologix to Participate in Two Investor Conferences in September 2016
September 06 2016 - 9:00AM
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative
treatments for aortic disorders, announced today that John
McDermott, Chief Executive Officer, is scheduled to participate at
two investor conferences in September 2016. The first conference is
the Morgan Stanley Global Healthcare Conference 2016 in New York,
NY.
Event: |
Morgan Stanley Global Healthcare Conference
2016 |
Date: |
Tuesday, September 13, 2016 |
Time: |
5:15 pm ET / 2:15 pm PT |
The second conference is the 7th Annual Credit
Suisse Small & Mid Cap Conference in New York, NY. This
conference will allow institutional investors to meet with the
Company but does not include a formal presentation.
Event: |
7th Annual Credit Suisse Small & Mid Cap
Conference |
Date: |
Wednesday, September 14, 2016 |
An audio webcast of the Company’s presentation at
the Morgan Stanley Global Healthcare Conference 2016 will be
available by visiting the investor relations section of Endologix’s
website at www.endologix.com. A replay of the presentation will be
available for 30 days.
About Endologix, Inc.Endologix,
Inc. develops and manufactures minimally invasive treatments for
aortic disorders. The Company's focus is endovascular stent grafts
for the treatment of abdominal aortic aneurysms (AAA). AAA is a
weakening of the wall of the aorta, the largest artery in the body,
resulting in a balloon-like enlargement. Once AAA develops, it
continues to enlarge and, if left untreated, becomes increasingly
susceptible to rupture. The overall patient mortality rate for
ruptured AAA is approximately 80%, making it a leading cause of
death in the U.S. Additional information can be found on
Endologix's website at www.endologix.com.
COMPANY CONTACT:
Endologix, Inc.
John McDermott, CEO
Vaseem Mahboob, CFO
(949) 595-7200
www.endologix.com
INVESTOR CONTACTS:
The Ruth Group
Nick Laudico (646) 536-7030
Zack Kubow (646) 536-7020
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Apr 2023 to Apr 2024